Investigator's Initiated Phase II Study for Pancreatic Cancer Patients
Clinical trial NCT01659502 · UNKNOWN
Trial details
- NCT number
- NCT01659502
- Sponsor
- Tiltan Pharma Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.